Zinc transporter type 8 autoantibodies (ZnT8A): prevalence and phenotypic associations in latent autoimmune diabetes patients and patients with adult onset type 1 diabetes

References

• Wenzlau J. M., Juhl K., Yu L., . The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes. Proc. Natl. Acad. Sci. USA. 2007; 104:17040–17045.
   PubMed Web of Science ®Google Scholar
• Knip M., Siljander H.. Autoimmune mechanisms in type 1 diabetes. Autoimmun. Rev.. 2008; 7:550–557.
   PubMed Web of Science ®Google Scholar
• Chimienti F., Devergnas S., Pattou F., . In vivo expression and functional characterization of the zinc transporter ZnT8 in glucose-induced insulin secretion. J. Cell Sci.. 2006; 119:4199–4206.
   Google Scholar
• Cauchi S., Del Guerra S., Choquet H., . Meta-analysis and functional effects of the SLC30A8 rs13266634 polymorphism on isolated human pancreatic islets. Mol. Genet. Metab.. 2010; 100:77–82.
   Google Scholar
• Pettersen E., Skorpen F., Kvaloy K., Midthjell K., Grill V.. Genetic heterogeneity in latent autoimmune diabetes is linked to various degrees of autoimmune activity: results from the Nord-Trondelag Health Study. Diabetes. 2010; 59:302–310.
   PubMedGoogle Scholar
• Xu K., Zha M., Wu X., . Association between rs13266634 C/T polymorphisms of solute carrier family 30 member 8 (SLC30A8) and type 2 diabetes, impaired glucose tolerance, type 1 diabetes—A meta-analysis. Diabetes Res. Clin. Pract.. 2011; 91:195–202.
   PubMed Web of Science ®Google Scholar
• Steinthorsdottir V., Thorleifsson G., Reynisdottir I., . A variant in CDKAL1 influences insulin response and risk of type 2 diabetes. Nat Genet. 2007; 39:770–775.
   PubMed Web of Science ®Google Scholar
• Staiger H., Machicao F., Stefan N., . Polymorphisms within novel risk loci for type 2 diabetes determine beta-cell function. PLoS One. 2007; 2:e832.
   PubMed Web of Science ®Google Scholar
• Kirchhoff K., Machicao F., Haupt A., . Polymorphisms in the TCF7L2, CDKAL1 and SLC30A8 genes are associated with impaired proinsulin conversion. Diabetologia. 2008; 51:597–601.
   PubMed Web of Science ®Google Scholar
• Boesgaard T. W., Zilinskaite J., Vanttinen M., . The common SLC30A8 Arg325Trp variant is associated with reduced first-phase insulin release in 846 non-diabetic offspring of type 2 diabetes patients—The EUGENE2 study. Diabetologia. 2008; 51:816–820.
   PubMed Web of Science ®Google Scholar
• Wenzlau J. M., Liu Y., Yu L., . A common nonsynonymous single nucleotide polymorphism in the SLC30A8 gene determines ZnT8 autoantibody specificity in type 1 diabetes. Diabetes. 2008; 57:2693–2697.
   PubMed Web of Science ®Google Scholar
• van Deutekom A. W., Heine R. J., Simsek S.. The islet autoantibody titres: their clinical relevance in latent autoimmune diabetes in adults (LADA) and the classification of diabetes mellitus. Diabet. Med.. 2008; 25:117–125.
   PubMed Web of Science ®Google Scholar
• Groop L., Forsblom C., Lehtovirta M., . Metabolic consequences of a family history of NIDDM (the Botnia study): evidence for sex-specific parental effects. Diabetes. 1996; 45:1585–1593.
   PubMed Web of Science ®Google Scholar
• Thorn L. M., Forsblom C., Fagerudd J., . Metabolic syndrome in type 1 diabetes: association with diabetic nephropathy and glycemic control (the FinnDiane study). Diabetes Care. 2005; 28:2019–2024.
   PubMedGoogle Scholar
• Hanson R. L., Pratley R. E., Bogardus C., . Evaluation of simple indices of insulin sensitivity and insulin secretion for use in epidemiologic studies. Am. J. Epidemiol.. 2000; 151:190–198.
   PubMed Web of Science ®Google Scholar
• Tuomi T., Carlsson A., Li H., . Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies. Diabetes. 1999; 48:150–157.
   PubMed Web of Science ®Google Scholar
• Lampasona V., Schlosser M., Mueller P. W., . Diabetes antibody standardization program: first proficiency evaluation of assays for autoantibodies to zinc transporter 8. Clin. Chem.. 2011; 57:1693–1702.
   PubMed Web of Science ®Google Scholar
• Isomaa B., Forsen B., Lahti K., . A family history of diabetes is associated with reduced physical fitness in the Prevalence, Prediction and Prevention of Diabetes (PPP)–Botnia study. Diabetologia. 2010; 53:1709–1713.
   PubMed Web of Science ®Google Scholar
• Sjoroos M., Iitia A., Ilonen J., Reijonen H., Lovgren T.. Triple-label hybridization assay for type-1 diabetes-related HLA alleles. BioTechniques. 1995; 18:870–877.
   PubMed Web of Science ®Google Scholar
• Kawasaki E., Uga M., Nakamura K., . Association between anti-ZnT8 autoantibody specificities and SLC30A8 Arg325Trp variant in Japanese patients with type 1 diabetes. Diabetologia. 2008; 51:2299–2302.
   PubMed Web of Science ®Google Scholar
• Vaziri-Sani F., Oak S., Radtke J., . ZnT8 autoantibody titers in type 1 diabetes patients decline rapidly after clinical onset. Autoimmunity. 2010; 43:598–606.
   PubMed Web of Science ®Google Scholar
• Kawasaki E., Nakamura K., Kuriya G., . Differences in the humoral autoreactivity to zinc transporter 8 between childhood- and adult-onset type 1 diabetes in Japanese patients. Clin. Immunol.. 2011; 138:146–153.
   PubMed Web of Science ®Google Scholar
• Wenzlau J. M., Walter M., Gardner T. J., . Kinetics of the post-onset decline in zinc transporter 8 autoantibodies in type 1 diabetic human subjects. J. Clin. Endocrinol. Metab.. 2010; 95:4712–4719.
   PubMed Web of Science ®Google Scholar
• Nielsen L. B., Vaziri-Sani F., Porksen S., . Relationship between ZnT8Ab, the SLC30A8 gene and disease progression in children with newly diagnosed type 1 diabetes. Autoimmunity. 2011; 44:616–623.
   PubMed Web of Science ®Google Scholar
• Brorsson C., Vaziri-Sani F., Bergholdt R., . Correlations between islet autoantibody specificity and the SLC30A8 genotype with HLA-DQB1 and metabolic control in new onset type 1 diabetes. Autoimmunity. 2011; 44:107–114.
   PubMed Web of Science ®Google Scholar
• Andersson C., Larsson K., Vaziri-Sani F., . The three ZNT8 autoantibody variants together improve the diagnostic sensitivity of childhood and adolescent type 1 diabetes. Autoimmunity. 2011; 44:394–405.
   PubMed Web of Science ®Google Scholar
• Howson J. M., Krause S., Stevens H., . Genetic association of zinc transporter 8 (ZnT8) autoantibodies in type 1 diabetes cases. Diabetologia. 2012; 55:1978–1984.
   PubMedGoogle Scholar
• Trabucchi A., Faccinetti N. I., Guerra L. L., . Detection and characterization of ZnT8 autoantibodies could help to screen latent autoimmune diabetes in adult-onset patients with type 2 phenotype. Autoimmunity. 2012; 45:137–142.
   PubMed Web of Science ®Google Scholar
• Lampasona V., Petrone A., Tiberti C., . Zinc transporter 8 antibodies complement GAD and IA-2 antibodies in the identification and characterization of adult-onset autoimmune diabetes: Non Insulin Requiring Autoimmune Diabetes (NIRAD) 4. Diabetes Care. 2010; 33:104–108.
   PubMed Web of Science ®Google Scholar
• Kawasaki E., Nakamura K., Kuriya G., . Autoantibodies to insulin, insulinoma-associated antigen-2, and zinc transporter 8 improve the prediction of early insulin requirement in adult-onset autoimmune diabetes. J Clin Endocrinol Metab. 2010; 95:707–713.
   PubMed Web of Science ®Google Scholar
• Zampetti S., Spoletini M., Petrone A., . Association of TCF7L2 gene variants with low GAD autoantibody titre in LADA subjects (NIRAD Study 5). Diabet. Med.. 2010; 27:701–704.
   PubMedGoogle Scholar
• Buzzetti R., Di Pietro S., Giaccari A., . High titer of autoantibodies to GAD identifies a specific phenotype of adult-onset autoimmune diabetes. Diabetes Care. 2007; 30:932–938.
   PubMed Web of Science ®Google Scholar
• Andersen M. K., Lundgren V., Turunen J. A., . Latent autoimmune diabetes in adults differs genetically from classical type 1 diabetes diagnosed after the age of 35 years. Diabetes Care. 2010; 33:2062–2064.
   PubMedGoogle Scholar
• Petrone A., Suraci C., Capizzi M., . The protein tyrosine phosphatase nonreceptor 22 (PTPN22) is associated with high GAD antibody titer in latent autoimmune diabetes in adults: Non Insulin Requiring Autoimmune Diabetes (NIRAD) Study 3. Diabetes Care. 2008; 31:534–538.
   PubMed Web of Science ®Google Scholar
• Nicolson T. J., Bellomo E. A., Wijesekara N., . Insulin storage and glucose homeostasis in mice null for the granule zinc transporter ZnT8 and studies of the type 2 diabetes-associated variants. Diabetes. 2009; 58:2070–2083.
   PubMed Web of Science ®Google Scholar
• Fu Y., Tian W., Pratt E. B., . Down-regulation of ZnT8 expression in INS-1 rat pancreatic beta cells reduces insulin content and glucose-inducible insulin secretion. PLoS One. 2009; 4:e5679.
   Web of Science ®Google Scholar